Literature DB >> 31969387

Cutting Edge: The RNA-Binding Protein Ewing Sarcoma Is a Novel Modulator of Lymphotoxin β Receptor Signaling.

Richard Virgen-Slane1, Ricardo G Correa1, Parham Ramezani-Rad2, Seth Steen-Fuentes1, Thiago Detanico1, Michael J DiCandido3, Jun Li3, Carl F Ware4.   

Abstract

Lymphotoxin β receptor (LTβR) signaling is crucial for lymphoid tissue organogenesis and immune homeostasis. To identify novel regulatory mechanisms for signaling, we implemented a two-step screen that uses coexpression analysis of human fibroblasts undergoing LTβR stimulation and affinity-purification mass spectrometry for the LTβR signaling protein TNFR-associated factor 3 (TRAF3). We identify Ewing sarcoma (EWS) protein as a novel LTβR signaling component that associates with TRAF3 but not with TNFR-associated factor 2 (TRAF2). The EWS:TRAF3 complex forms under unligated conditions that are disrupted following activation of the LTβR. We conclude that EWS limits expression of proinflammatory molecules, GM-CSF, and ERK-2, promoting immune homeostasis.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31969387      PMCID: PMC7033016          DOI: 10.4049/jimmunol.1901260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Using GOstats to test gene lists for GO term association.

Authors:  S Falcon; R Gentleman
Journal:  Bioinformatics       Date:  2006-11-10       Impact factor: 6.937

Review 2.  Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease.

Authors:  Jeffrey L Browning
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

3.  Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.

Authors:  Hideki Sanjo; Dirk M Zajonc; Rebecca Braden; Paula S Norris; Carl F Ware
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

4.  TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.

Authors:  Pradeep Bista; Weike Zeng; Sarah Ryan; Veronique Bailly; Jeffrey L Browning; Matvey E Lukashev
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

5.  ERK is an anti-inflammatory signal that suppresses expression of NF-kappaB-dependent inflammatory genes by inhibiting IKK activity in endothelial cells.

Authors:  Yong-Sun Maeng; Jeong-Ki Min; Jeong Hun Kim; Akiko Yamagishi; Naoki Mochizuki; Ja-Young Kwon; Yong-Won Park; Young-Myeong Kim; Young-Guen Kwon
Journal:  Cell Signal       Date:  2005-10-20       Impact factor: 4.315

6.  The TNF Family Molecules LIGHT and Lymphotoxin αβ Induce a Distinct Steroid-Resistant Inflammatory Phenotype in Human Lung Epithelial Cells.

Authors:  Ricardo da Silva Antunes; Lisa Madge; Pejman Soroosh; Joel Tocker; Michael Croft
Journal:  J Immunol       Date:  2015-07-24       Impact factor: 5.422

7.  Lymphotoxin beta-mediated stimulation of synoviocytes in rheumatoid arthritis.

Authors:  Andrea Braun; Seisuke Takemura; Abbe N Vallejo; Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Rheum       Date:  2004-07

8.  NF-kappa B-inducing kinase regulates selected gene expression in the Nod2 signaling pathway.

Authors:  Qilin Pan; Vladimir Kravchenko; Alex Katz; Shuang Huang; Masayuki Ii; John C Mathison; Koichi Kobayashi; Richard A Flavell; Robert D Schreiber; David Goeddel; Richard J Ulevitch
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  POSTAR2: deciphering the post-transcriptional regulatory logics.

Authors:  Yumin Zhu; Gang Xu; Yucheng T Yang; Zhiyu Xu; Xinduo Chen; Binbin Shi; Daoxin Xie; Zhi John Lu; Pengyuan Wang
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  SAINTexpress: improvements and additional features in Significance Analysis of INTeractome software.

Authors:  Guoci Teo; Guomin Liu; Jianping Zhang; Alexey I Nesvizhskii; Anne-Claude Gingras; Hyungwon Choi
Journal:  J Proteomics       Date:  2013-10-26       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.